It's early days guys. I see PAA as quiet with high potential. As a pre-approved drug to which we own patent uses for, any signal of shining light will see things accelerate very quickly as we will have very little paperwork and rigmarole to get it off the ground. Keep an eye out for epichem too. I think mid-year we will start to see things really moving.
Ann: Shareholder Update - Human & Canine Trials, page-6
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $86.77M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.8¢ | 19.5¢ | $67.86K | 346.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 360690 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 792103 | 8 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |